Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent
暂无分享,去创建一个
M. Murray | D. Dickson | Z. Wszolek | P. McLean | J. Carr | O. Ross | F. Fiesel | W. Springer | Xu Hou | S. Koga | M. Delenclos | G. Bu | Jenny M. Bredenberg | Ayman H Faroqi | Taylor Hsuan-Yu Chen
[1] D. Klenerman,et al. Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity , 2022, Nature Neuroscience.
[2] S. K. Barodia,et al. Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and function , 2022, Acta neuropathologica communications.
[3] I. McKeith,et al. α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity , 2022, Proceedings of the National Academy of Sciences of the United States of America.
[4] D. Dickson,et al. Neuropathology and molecular diagnosis of Synucleinopathies , 2021, Molecular Neurodegeneration.
[5] S. Gunawardena,et al. Differential mitochondrial roles for α-synuclein in DRP1-dependent fission and PINK1/Parkin-mediated oxidation , 2021, Cell Death & Disease.
[6] D. Dickson,et al. Deep learning‐based model for diagnosing Alzheimer's disease and tauopathies , 2021, Neuropathology and applied neurobiology.
[7] T. Kunath,et al. Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy , 2021, bioRxiv.
[8] M. Feany,et al. α-synuclein impairs autophagosome maturation through abnormal actin stabilization , 2021, PLoS genetics.
[9] M. Meyer,et al. Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson’s Disease , 2021, Cells.
[10] I. McKeith,et al. Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders , 2021, Acta Neuropathologica.
[11] D. Dickson,et al. Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples , 2020, Autophagy.
[12] L. Petrucelli,et al. Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[13] V. Baekelandt,et al. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies , 2020, Acta Neuropathologica.
[14] H. Ruley,et al. Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein , 2020, Science Advances.
[15] M. Goldberg,et al. Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein Fibrils , 2020, Neuroscience.
[16] G. Knott,et al. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration , 2020, Proceedings of the National Academy of Sciences.
[17] F. Fiesel,et al. Autophagy in Parkinson's disease. , 2020, Journal of molecular biology.
[18] M. Tagliati,et al. iPSC modeling of young-onset Parkinson’s disease reveals a molecular signature of disease and novel therapeutic candidates , 2020, Nature Medicine.
[19] D. Selkoe,et al. Parkinson’s disease: proteinopathy or lipidopathy? , 2020, npj Parkinson's Disease.
[20] D. Klenerman,et al. Analysis of α-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies , 2020, Brain communications.
[21] J. Kordower,et al. Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let’s talk about the lipids in the room , 2019, npj Parkinson's Disease.
[22] G. Monzio Compagnoni,et al. Understanding the pathogenesis of multiple system atrophy: state of the art and future perspectives , 2019, Acta neuropathologica communications.
[23] W. V. van IJcken,et al. Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes , 2019, Nature Neuroscience.
[24] A. Lieberman,et al. Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration , 2019, Acta neuropathologica communications.
[25] M. Goldberg,et al. Analysis of α-Synuclein Pathology in PINK1 Knockout Rat Brains , 2019, Front. Neurosci..
[26] M. Farrer,et al. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease , 2018, Autophagy.
[27] P. McLean,et al. Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway , 2018, bioRxiv.
[28] Xinnan Wang,et al. Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson’s models , 2018, Acta Neuropathologica.
[29] John L. Robinson,et al. Cellular Milieu Imparts Distinct Pathological α-Synuclein Strains in α-Synucleinopathies , 2018, Nature.
[30] N. Kamasawa,et al. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson’s disease , 2018, Proceedings of the National Academy of Sciences.
[31] M. Feany,et al. α-synuclein Induces Mitochondrial Dysfunction through Spectrin and the Actin Cytoskeleton , 2018, Neuron.
[32] D. Galasko,et al. Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype , 2018, Autophagy.
[33] Federico N. Soria,et al. Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease , 2017, Scientific Reports.
[34] Michael J. Devine,et al. α-Synuclein binds to the ER–mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production , 2017, Acta Neuropathologica.
[35] T. Caulfield,et al. PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson’s Disease Pathobiology? , 2016, Journal of Parkinson's disease.
[36] A. Mrejeru,et al. Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation , 2016, Stem cell reports.
[37] Caitlyn W. Barrett,et al. α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease , 2016, Science Translational Medicine.
[38] P. Calabresi,et al. Lysosomal Dysfunction and α‐Synuclein Aggregation in Parkinson's Disease: Diagnostic Links , 2016, Movement disorders : official journal of the Movement Disorder Society.
[39] M. Xilouri,et al. Autophagy and Alpha‐Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies , 2016, Movement disorders : official journal of the Movement Disorder Society.
[40] D. Dickson,et al. Autosomal dominant Parkinson's disease caused by SNCA duplications. , 2016, Parkinsonism & related disorders.
[41] Takeo Kato,et al. Sensitive western blotting for detection of endogenous Ser129-phosphorylated α-synuclein in intracellular and extracellular spaces , 2015, Scientific Reports.
[42] Elisabeth L. Moussaud-Lamodière,et al. (Patho‐)physiological relevance of PINK1‐dependent ubiquitin phosphorylation , 2015, EMBO reports.
[43] M. Giugliano,et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration , 2015, Nature.
[44] P. McLean,et al. Targeting α-synuclein oligomers by protein-fragment complementation for drug discovery in synucleinopathies , 2015, Expert opinion on therapeutic targets.
[45] K. Lim,et al. Convergence of Parkin, PINK1, and α-Synuclein on Stress-induced Mitochondrial Morphological Remodeling* , 2015, The Journal of Biological Chemistry.
[46] Richard Wade-Martins,et al. Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease. , 2015, Trends in biochemical sciences.
[47] X. Zhuang,et al. A53T Human α-Synuclein Overexpression in Transgenic Mice Induces Pervasive Mitochondria Macroautophagy Defects Preceding Dopamine Neuron Degeneration , 2015, The Journal of Neuroscience.
[48] J. Roeper,et al. Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression , 2014, Human molecular genetics.
[49] V. Baekelandt,et al. Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice , 2014, Neurobiology of Aging.
[50] C. Páyan-Gomez,et al. Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease. , 2014, Biochimica et biophysica acta.
[51] G. Halliday,et al. α-Synucleinopathy phenotypes. , 2014, Parkinsonism & related disorders.
[52] D. Dickson,et al. Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutations. , 2013, American journal of neurodegenerative disease.
[53] Ssang-Goo Cho,et al. Autophagic failure promotes the exocytosis and intercellular transfer of α-synuclein , 2013, Experimental & Molecular Medicine.
[54] Y. Tohyama,et al. Tubulin Polymerization-promoting Protein (TPPP/p25α) Promotes Unconventional Secretion of α-Synuclein through Exophagy by Impairing Autophagosome-Lysosome Fusion* , 2013, The Journal of Biological Chemistry.
[55] Yi Zhang,et al. Direct Conversion of Fibroblasts to Neurons by Reprogramming PTB-Regulated MicroRNA Circuits , 2013, Cell.
[56] M. Xilouri,et al. Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship , 2013, Molecular Neurobiology.
[57] H. Okano,et al. Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue , 2012, Molecular Brain.
[58] Patrick A. Lewis,et al. Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus , 2011, Nature communications.
[59] T. Kamitani,et al. Improved Immunodetection of Endogenous α-Synuclein , 2011, PloS one.
[60] R. Nussbaum,et al. Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein*♦ , 2011, The Journal of Biological Chemistry.
[61] V. Choubey,et al. Mutant A53T α-Synuclein Induces Neuronal Death by Increasing Mitochondrial Autophagy* , 2011, The Journal of Biological Chemistry.
[62] C. Oliveira,et al. Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD , 2011, Parkinson's disease.
[63] Thomas Gasser,et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria , 2009, The Lancet Neurology.
[64] John Hardy,et al. Parkinson's disease , 2009, The Lancet.
[65] B. E. Staveley,et al. Pink1 suppresses alpha-synuclein-induced phenotypes in a Drosophila model of Parkinson's disease. , 2008, Genome.
[66] V. Bader,et al. Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage. , 2007, Human molecular genetics.
[67] S. Miyachi,et al. Neuronal specificity of α-synuclein toxicity and effect of Parkin co-expression in primates , 2007, Neuroscience.
[68] D. Price,et al. Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death , 2006, The Journal of Neuroscience.
[69] C. Ross,et al. Parkin Mediates Nonclassical, Proteasomal-Independent Ubiquitination of Synphilin-1: Implications for Lewy Body Formation , 2005, The Journal of Neuroscience.
[70] T. Iwatsubo,et al. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[71] B. Hyman,et al. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. , 2002, The American journal of pathology.
[72] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[73] C. Ross,et al. Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease , 2001, Nature Medicine.
[74] M. Farrer,et al. Distinctive neuropathology revealed by α-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p , 2000, Acta Neuropathologica.
[75] L. Mucke,et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.